Annual Total Long Term Liabilities
$823.85 M
-$78.38 M-8.69%
31 December 2023
Summary:
IDEXX Laboratories annual total long term liabilities is currently $823.85 million, with the most recent change of -$78.38 million (-8.69%) on 31 December 2023. During the last 3 years, it has fallen by -$255.16 million (-23.65%). IDXX annual total long term liabilities is now -23.65% below its all-time high of $1.08 billion, reached on 31 December 2020.IDXX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$723.49 M
+$5.58 M+0.78%
30 September 2024
Summary:
IDEXX Laboratories quarterly total long term liabilities is currently $723.49 million, with the most recent change of +$5.58 million (+0.78%) on 30 September 2024. Over the past year, it has dropped by -$95.32 million (-11.64%). IDXX quarterly long term liabilities is now -36.91% below its all-time high of $1.15 billion, reached on 30 June 2020.IDXX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IDXX Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -8.7% | -11.6% |
3 y3 years | -23.6% | -27.4% |
5 y5 years | +6.2% | -21.5% |
IDXX Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -23.6% | at low | -27.4% | +0.8% |
5 y | 5 years | -23.6% | +6.2% | -36.9% | +0.8% |
alltime | all time | -23.6% | >+9999.0% | -36.9% | >+9999.0% |
IDEXX Laboratories Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $723.49 M(+0.8%) |
June 2024 | - | $717.91 M(-13.3%) |
Mar 2024 | - | $827.71 M(+0.5%) |
Dec 2023 | $823.85 M(-8.7%) | $823.85 M(+0.6%) |
Sept 2023 | - | $818.80 M(-8.3%) |
June 2023 | - | $893.09 M(-1.0%) |
Mar 2023 | - | $901.67 M(-0.1%) |
Dec 2022 | $902.23 M(-8.3%) | $902.23 M(-7.4%) |
Sept 2022 | - | $974.12 M(-1.0%) |
June 2022 | - | $983.63 M(+0.2%) |
Mar 2022 | - | $981.55 M(-0.2%) |
Dec 2021 | $983.63 M(-8.8%) | $983.63 M(-1.3%) |
Sept 2021 | - | $996.43 M(-1.5%) |
June 2021 | - | $1.01 B(+0.9%) |
Mar 2021 | - | $1.00 B(-7.0%) |
Dec 2020 | $1.08 B(+16.1%) | $1.08 B(-0.0%) |
Sept 2020 | - | $1.08 B(-5.9%) |
June 2020 | - | $1.15 B(+23.0%) |
Mar 2020 | - | $931.95 M(+0.3%) |
Dec 2019 | $929.31 M(+19.7%) | $929.31 M(+0.8%) |
Sept 2019 | - | $922.13 M(-1.2%) |
June 2019 | - | $933.78 M(-0.6%) |
Mar 2019 | - | $939.48 M(+21.0%) |
Dec 2018 | $776.14 M(+1.8%) | $776.14 M(-1.3%) |
Sept 2018 | - | $786.36 M(-0.1%) |
June 2018 | - | $787.22 M(-0.3%) |
Mar 2018 | - | $789.64 M(+3.5%) |
Dec 2017 | $762.69 M(+8.3%) | $762.69 M(+5.8%) |
Sept 2017 | - | $721.18 M(-0.1%) |
June 2017 | - | $721.75 M(+1.7%) |
Mar 2017 | - | $709.93 M(+0.8%) |
Dec 2016 | $704.35 M(+0.3%) | $704.35 M(+2.8%) |
Sept 2016 | - | $685.18 M(+1.5%) |
June 2016 | - | $674.96 M(+0.2%) |
Mar 2016 | - | $673.77 M(-4.1%) |
Dec 2015 | $702.23 M(+57.6%) | $702.23 M(+1.6%) |
Sept 2015 | - | $691.25 M(-0.3%) |
June 2015 | - | $693.39 M(+16.8%) |
Mar 2015 | - | $593.49 M(+33.2%) |
Dec 2014 | $445.72 M(+90.5%) | $445.72 M(+3.4%) |
Sept 2014 | - | $430.90 M(+87.4%) |
June 2014 | - | $229.91 M(-1.3%) |
Mar 2014 | - | $232.90 M(-0.4%) |
Dec 2013 | $233.95 M(+283.4%) | $233.95 M(+247.2%) |
Sept 2013 | - | $67.39 M(+7.3%) |
June 2013 | - | $62.81 M(+1.7%) |
Mar 2013 | - | $61.77 M(+1.2%) |
Dec 2012 | $61.01 M(+12.3%) | $61.01 M(+1.7%) |
Sept 2012 | - | $59.97 M(+3.0%) |
June 2012 | - | $58.23 M(+2.3%) |
Mar 2012 | - | $56.94 M(+4.8%) |
Dec 2011 | $54.34 M | $54.34 M(+16.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2011 | - | $46.86 M(+7.4%) |
June 2011 | - | $43.63 M(+9.1%) |
Mar 2011 | - | $40.00 M(+6.0%) |
Dec 2010 | $37.75 M(+0.3%) | $37.75 M(-15.6%) |
Sept 2010 | - | $44.71 M(+16.9%) |
June 2010 | - | $38.26 M(+0.7%) |
Mar 2010 | - | $37.98 M(+0.9%) |
Dec 2009 | $37.64 M(+17.8%) | $37.64 M(-67.7%) |
Sept 2009 | - | $116.69 M(+1.6%) |
June 2009 | - | $114.83 M(+253.0%) |
Mar 2009 | - | $32.53 M(+1.8%) |
Dec 2008 | $31.95 M(-21.0%) | $31.95 M(-5.0%) |
Sept 2008 | - | $33.62 M(-10.1%) |
June 2008 | - | $37.38 M(-2.1%) |
Mar 2008 | - | $38.20 M(-5.6%) |
Dec 2007 | $40.46 M(+62.1%) | $40.46 M(-9.9%) |
Sept 2007 | - | $44.92 M(-6.5%) |
June 2007 | - | $48.05 M(+4.5%) |
Mar 2007 | - | $45.99 M(+84.3%) |
Dec 2006 | $24.96 M(+68.6%) | $24.96 M(+20.8%) |
Sept 2006 | - | $20.66 M(-1.8%) |
June 2006 | - | $21.02 M(+54.3%) |
Mar 2006 | - | $13.63 M(-7.9%) |
Dec 2005 | $14.80 M(-8.8%) | $14.80 M(+5.8%) |
Sept 2005 | - | $13.99 M(-3.8%) |
June 2005 | - | $14.54 M(-5.7%) |
Mar 2005 | - | $15.42 M(-5.0%) |
Dec 2004 | $16.23 M(+97.1%) | $16.23 M(+75.9%) |
Sept 2004 | - | $9.23 M(-8.6%) |
June 2004 | - | $10.10 M(+5.8%) |
Mar 2004 | - | $9.54 M(+15.8%) |
Dec 2003 | $8.24 M(+33.3%) | $8.24 M(+32.8%) |
Sept 2003 | - | $6.20 M(+10.0%) |
June 2003 | - | $5.64 M(-2.0%) |
Mar 2003 | - | $5.75 M(-6.9%) |
Dec 2002 | $6.18 M(>+9900.0%) | $6.18 M(>+9900.0%) |
Dec 1999 | $41.00 K(-99.0%) | $41.00 K(-99.0%) |
Sept 1999 | - | $4.20 M(0.0%) |
June 1999 | - | $4.20 M(0.0%) |
Mar 1999 | - | $4.20 M(0.0%) |
Dec 1998 | $4.20 M(+4100.0%) | $4.20 M(+4100.0%) |
Sept 1998 | - | $100.00 K(0.0%) |
June 1997 | - | $100.00 K(0.0%) |
Dec 1996 | $100.00 K(-200.0%) | $100.00 K(-200.0%) |
Sept 1996 | - | -$100.00 K(0.0%) |
Sept 1995 | - | -$100.00 K(0.0%) |
Dec 1994 | -$100.00 K(-200.0%) | -$100.00 K(-200.0%) |
Mar 1994 | - | $100.00 K(0.0%) |
Dec 1993 | $100.00 K(-200.0%) | $100.00 K(0.0%) |
Mar 1993 | - | $100.00 K(-200.0%) |
Dec 1992 | -$100.00 K | -$100.00 K(-200.0%) |
Sept 1991 | - | $100.00 K |
FAQ
- What is IDEXX Laboratories annual total long term liabilities?
- What is the all time high annual total long term liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories annual total long term liabilities year-on-year change?
- What is IDEXX Laboratories quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for IDEXX Laboratories?
- What is IDEXX Laboratories quarterly long term liabilities year-on-year change?
What is IDEXX Laboratories annual total long term liabilities?
The current annual total long term liabilities of IDXX is $823.85 M
What is the all time high annual total long term liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high annual total long term liabilities is $1.08 B
What is IDEXX Laboratories annual total long term liabilities year-on-year change?
Over the past year, IDXX annual total long term liabilities has changed by -$78.38 M (-8.69%)
What is IDEXX Laboratories quarterly total long term liabilities?
The current quarterly long term liabilities of IDXX is $723.49 M
What is the all time high quarterly long term liabilities for IDEXX Laboratories?
IDEXX Laboratories all-time high quarterly total long term liabilities is $1.15 B
What is IDEXX Laboratories quarterly long term liabilities year-on-year change?
Over the past year, IDXX quarterly total long term liabilities has changed by -$95.32 M (-11.64%)